Callan JMB Inc. enters the week in a peculiar position: short interest has dropped sharply over seven days, yet the cost to borrow remains nearly 45% annualised — a combination that suggests the selloff is less about rising conviction on the short side and more about forced unwinds on a heavily concentrated micro-cap.
The borrow picture tells the more compelling story. Shorting CJMB is expensive. Cost to borrow clocked in at 45.0% APR on May 14, down from a peak above 69% in early April but still elevated relative to the broad market. Availability is now running at 314%, meaning there are roughly three shares available to lend for every one currently shorted — a marked loosening from the near-fully-tapped conditions seen in early April, when availability had tightened dramatically and borrow costs were highest. Short interest itself has retreated hard: down 30% in a week to 1.74% of the float, reversing a 43% build over the prior month. The ORTEX short score has also pulled back from a week-ago peak of 67.4 to 57.9, confirming the directional shift away from peak bearish positioning.
The stock's own performance complicates the picture. CJMB closed at $1.01 on May 15, down 11% for the week and 7% for the month. That price action points to selling pressure that predates this week's short-covering — yet the modest 1% bounce on Thursday suggests some stabilisation near the $1 mark. At a market cap of roughly $5.7 million, this is a micro-cap with thin liquidity, and moves can be outsized relative to what the numbers suggest.
Ownership is highly concentrated. Founder, Chairman, and CEO Wayne Williams controls 42% of shares. Director David Croyle holds a further 14%. Together, those two alone account for more than half the company — leaving remarkably little float for the short sellers to work with, which helps explain why even modest short interest creates material borrow costs. The most recent disclosed institutional activity shows Bard Associates trimming 40,380 shares as of May 13, while Creative Planning added 50,000 shares as recently as late March.
Insider buying has been a consistent theme since December. Williams made multiple open-market purchases at prices between $1.65 and $1.79 through December 2025, accumulating more than 65,000 shares. Croyle added another 25,000 shares across two purchases in early March 2026, paying around $1.76. All these buys came at prices meaningfully above the current $1.01 close, making them unrealised losers for now — a fact worth noting as the stock hovers near its one-dollar level.
The earnings reaction history adds further texture. The last four events produced swings of +7%, -11%, -10%, and +6% on the day, with no consistent directional pattern. No next earnings date is currently confirmed, so that trigger is not imminent. What the data leaves the reader watching instead is whether short interest — which compressed rapidly this week — stabilises near current levels or continues to unwind, and whether the $1.00 price level holds as a psychological floor for a stock that a cluster of insiders bought at a material premium.
See the live data behind this article on ORTEX.
Open CJMB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
